A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

October 31, 2013

Conditions
Small Cell Lung Cancer
Interventions
DRUG

IP

irinotecan+cisplatin

Trial Locations (14)

420-767

Soonchunhyang University Bucheon Hospital, Bucheon-si

705-717

Yeungnam University Hospital, Daegu

705-718

Daegu Catholic University Hospital, Daegu

660-702

Gyeongsang National University Hospital, Jinju

463-707

Seoul National University Bundang Hospital, Seongnam-si

110-744

Seoul National University Hospital, Seoul

110-746

Kangbuk Samsung Hospital, Seoul

120-752

Yonsei Cancer Center, Seoul

134-791

Seoul Veterans Hospital, Seoul

137-040

Kangnam St.Mary's Hospital, Seoul

138-736

Asan Medical Center, Seoul

151-756

Chung-Ang University Medical Center, Seoul

156-707

Seoul Municipal Boramae Hospital, Seoul

422-723

St.Vincent Hospital, Suwon

All Listed Sponsors
lead

Clinical Research Center for Solid Tumor, Korea

OTHER